ACROBiosystems

ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents. Not only to support the development of target therapeutics but also vaccines and diagnostics. The company employs an application-oriented development strategy, with a particular focus on product design, quality control and solution-based support. Their products and also their services enable everyone in the field of drug development to have a more intuitive and streamlined process.

ACROBiosystems’ catalog includes a comprehensive list of disease-related biomarkers and drug targets from common species such as humans and mice. All products are also produced from batch-to-batch with high quality and consistency. So that they satisfy the rigorous standards of pharmaceutical research and development.

Since the start of the SARS-CoV-2 pandemic, ACROBiosystems has been keeping a close eye on the development of the situation. Therefore they accelerated the development of SARS-CoV-2 antigen proteins, antibodies, kits and other related products to facilitate the development of serologic tests, therapeutic antibodies and vaccines.

ACROBiosystems continues to grow and adapt to bring more value to their customers. For example, providing more technical resources and custom services and initiating collaborations in the bio-industry community.

Main product lines

SARS-CoV-2 related products
Emerging mutants
SARS-CoV-2 related kits
Reagents for diagnostic development
Reagents for vaccine development
Bispecific antibody targets
Targets for ADCs
Targets for CAR-T cell therapy
Fc receptors
Immune checkpoint proteins
Biotinylated proteins
Full-length CD20 proteins
Trimeric TNFSF proteins with high purity verified by MALS

Main products

Neutralizing antibody titer assay kit: TAS-K022-96tests
Emerging mutants from SARS-CoV-2 variants
Proteins: CD19, FMC63, BCMA, CD3E & CD3D, CD47, CD20, FcRs, VEGFs, TIGIT, EGFR

If you require specific products or prices, then please contact us and we will be glad to assist!